New treatments for chronic hepatitis C
Jae Young Jang, Raymond T. Chung
Korean J Hepatol. 2010;16(3):263-277. Published online 2010 Sep 30 DOI: https://doi.org/10.3350/kjhep.2010.16.3.263
|
Citations to this article as recorded by
Wide variation in estimates of global prevalence and burden of chronic hepatitis B and C infection cited in published literature
S. K. Basnayake, P. J. Easterbrook
Journal of Viral Hepatitis.2016; 23(7): 545. CrossRef Task-based optimization of flip angle for fibrosis detection in T1-weighted MRI of liver
Jonathan F. Brand, Lars R. Furenlid, Maria I. Altbach, Jean-Philippe Galons, Achyut Bhattacharyya, Puneet Sharma, Tulshi Bhattacharyya, Ali Bilgin, Diego R. Martin
Journal of Medical Imaging.2016; 3(3): 035502. CrossRef Phylogenetic analysis of HCV subgenotypes in patients from Sichuan province in China based on the NS5B region
BIN NIE, GUANGJIONG ZHANG, YONGCAN GUO, QINGFENG LI, JINBO LIU, ZHIGUANG TU
International Journal of Molecular Medicine.2015; 36(4): 1028. CrossRef History and progress of antiviral drugs: From acyclovir to direct-acting antiviral agents (DAAs) for Hepatitis C
O.L. Bryan-Marrugo, J. Ramos-Jiménez, H. Barrera-Saldaña, A. Rojas-Martínez, R. Vidaltamayo, A.M. Rivas-Estilla
Medicina Universitaria.2015; 17(68): 165. CrossRef TRAIL Enhances Apoptosis of Human Hepatocellular Carcinoma Cells Sensitized by Hepatitis C Virus Infection: Therapeutic Implications
Jae Young Jang, Seong-Jun Kim, Eun Kyung Cho, Soung Won Jeong, Eui Ju Park, Woong Cheul Lee, Sae Hwan Lee, Sang Gyune Kim, Young Seok Kim, Hong Soo Kim, Boo Sung Kim, Wenyu Lin, Raymond T. Chung, Stephen J. Polyak
PLoS ONE.2014; 9(6): e98171. CrossRef Prevalência de anti-HCV em uma população privada de liberdade
Fernanda da Rosa, Marcelo Carneiro, Luciano Nunes Duro, Andreia Rosane de Moura Valim, Cézane Priscila Reuter, Miria Suzana Burgos, Lia Possuelo
Revista da Associação Médica Brasileira.2012; 58(5): 557. CrossRef Prevalência de anti-HCV em uma população privada de liberdade
Fernanda da Rosa, Marcelo Carneiro, Luciano Nunes Duro, Andreia Rosane de Moura Valim, Cézane Priscila Reuter, Miria Suzana Burgos, Lia Possuelo
Revista da Associação Médica Brasileira (English Edition).2012; 58(5): 557. CrossRef Efficacy and Tolerability of Peginterferon Alpha Plus Ribavirin in the Routine Daily Treatment of Chronic Hepatitis C Patients in Korea: A Multi-Center, Retrospective Observational Study
Sang Hoon Park, Choong Kee Park, Jin Woo Lee, Young Seok Kim, Sook-Hyang Jeong, Yun Soo im, Ju Hyun Kim, Seong Gyu Hwang, Kyu Sung Rim, Hyung Joon Yim, Jae Youn Cheong, Sung Won Cho, June Sung Lee, Young Min Park, Jeong Won Jang Chun Kyon Lee, Joo Hyun Sh
Gut and Liver.2012; 6(1): 98. CrossRef Prevalência de anti-HCV em uma população privada de liberdade
Fernanda da Rosa, Marcelo Carneiro, Luciano Nunes Duro, Andreia Rosane de Moura Valim, Cézane Priscila Reuter, Miria Suzana Burgos, Lia Possuelo
Revista da Associação Médica Brasileira.2012; 58(5): 557. CrossRef Emerging treatment advances in chronic hepatitis C
Michael E. Trigg
Community Oncology.2012;[Epub] CrossRef NS5A: A new target for antiviral drugs in the treatment of hepatitis C virus infection
Jose D. Debes, Coleman I. Smith
Hepatology.2012; 56(3): 797. CrossRef ARF1 and GBF1 Generate a PI4P-Enriched Environment Supportive of Hepatitis C Virus Replication
Leiliang Zhang, Zhi Hong, Wenyu Lin, Run-Xuan Shao, Kaku Goto, Victor W. Hsu, Raymond T. Chung, Jianming Qiu
PLoS ONE.2012; 7(2): e32135. CrossRef IL28B But Not ITPA Polymorphism Is Predictive of Response to Pegylated Interferon, Ribavirin, and Telaprevir Triple Therapy in Patients With Genotype 1 Hepatitis C
Kazuaki Chayama, C. Nelson Hayes, Hiromi Abe, Daiki Miki, Hidenori Ochi, Yoshiyasu Karino, Joji Toyota, Yusuke Nakamura, Naoyuki Kamatani, Hitomi Sezaki, Mariko Kobayashi, Norio Akuta, Fumitaka Suzuki, Hiromitsu Kumada
The Journal of Infectious Diseases.2011; 204(1): 84. CrossRef Chronic Hepatitis C
Jae Young Jang, Raymond T. Chung
Gut and Liver.2011; 5(2): 117. CrossRef
|